Epidemiology of Lyme borreliosis based on outpatient claims data of all people with statutory health insurance, Germany, 2019
- PMID: 35959689
- PMCID: PMC9373599
- DOI: 10.2807/1560-7917.ES.2022.27.32.2101193
Epidemiology of Lyme borreliosis based on outpatient claims data of all people with statutory health insurance, Germany, 2019
Abstract
IntroductionEvidence of nationwide and regional morbidity of Lyme borreliosis (LB) in Germany is lacking.AimsWe calculated the total number of incident LB cases in Germany in 2019, compared regional variations, investigated the extent of possible under-reporting in notification data and examined the association between high incidence areas and land cover composition.MethodsWe used outpatient claims data comprising information for people with statutory health insurance who visited a physician at least once between 2010 and 2019 in Germany (n = 71,411,504). The ICD-10 code A69.2 was used to identify incident LB patients. Spatial variations of LB were assessed by means of Global and Local Moran's Index at district level. Notification data were obtained for nine federal states with mandatory notification from the Robert Koch Institute (RKI).ResultsOf all insured, 128,177 were diagnosed with LB in 2019, corresponding to an incidence of 179 per 100,000 insured. The incidence varied across districts by a factor of 16 (range: 40-646 per 100,000). We identified four spatial clusters with high incidences. These clusters were associated with a significantly larger proportion of forests and agricultural areas than low incidence clusters. In 2019, 12,264 LB cases were reported to the RKI from nine federal states, while 69,623 patients with LB were found in claims data for those states. This difference varied considerably across districts.ConclusionsThese findings serve as a solid basis for regionally tailored population-based intervention programmes and can support modelling studies assessing the development of LB epidemiology under various climate change scenarios.
Keywords: Germany; Lyme borreliosis; claims data; incidence; notification data; regional variations.
Conflict of interest statement
Figures





Similar articles
-
Incidence of Lyme Borreliosis in Germany: Exploring Observed Trends Over Time Using Public Surveillance Data, 2016-2020.Vector Borne Zoonotic Dis. 2023 Apr;23(4):237-246. doi: 10.1089/vbz.2022.0046. Vector Borne Zoonotic Dis. 2023. PMID: 37071399 Free PMC article.
-
Incidence of Lyme Borreliosis in Germany: A retrospective observational healthcare claims study.Ticks Tick Borne Dis. 2024 May;15(3):102326. doi: 10.1016/j.ttbdis.2024.102326. Epub 2024 Feb 27. Ticks Tick Borne Dis. 2024. PMID: 38417196
-
Evaluating frequency, diagnostic quality, and cost of Lyme borreliosis testing in Germany: a retrospective model analysis.Clin Dev Immunol. 2012;2012:595427. doi: 10.1155/2012/595427. Epub 2011 Dec 27. Clin Dev Immunol. 2012. PMID: 22242037 Free PMC article.
-
Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005-2020).Vector Borne Zoonotic Dis. 2023 Apr;23(4):156-171. doi: 10.1089/vbz.2022.0071. Vector Borne Zoonotic Dis. 2023. PMID: 37071405 Free PMC article.
-
Incidence of Lyme Borreliosis in Europe: A Systematic Review (2005-2020).Vector Borne Zoonotic Dis. 2023 Apr;23(4):172-194. doi: 10.1089/vbz.2022.0070. Vector Borne Zoonotic Dis. 2023. PMID: 37071407 Free PMC article.
Cited by
-
Modelling the impact of climate and the environment on the spatiotemporal dynamics of Lyme borreliosis in Germany.EBioMedicine. 2025 May;115:105701. doi: 10.1016/j.ebiom.2025.105701. Epub 2025 Apr 28. EBioMedicine. 2025. PMID: 40300325 Free PMC article.
-
Seroepidemiology of Borrelia burgdorferi s.l. among German National Cohort (NAKO) Participants, Hanover.Microorganisms. 2022 Nov 17;10(11):2286. doi: 10.3390/microorganisms10112286. Microorganisms. 2022. PMID: 36422355 Free PMC article.
-
Seroprevalence, seroconversion and seroreversion of Borrelia burgdorferi-specific IgG antibodies in two population-based studies in children and adolescents, Germany, 2003 to 2006 and 2014 to 2017.Euro Surveill. 2023 Aug;28(34):2200855. doi: 10.2807/1560-7917.ES.2023.28.34.2200855. Euro Surveill. 2023. PMID: 37616114 Free PMC article.
-
Seropositivity of Borrelia burgdorferi s.l. in Germany-an analysis across four German National Cohort (NAKO) study sites.Sci Rep. 2023 Nov 30;13(1):21087. doi: 10.1038/s41598-023-47766-6. Sci Rep. 2023. PMID: 38036551 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical